DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release (Q43656901)

25 November 2017

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release (English)

1 reference

25 November 2017

0 references

J Ichikawa

1

1 reference

25 November 2017

J Dai

series ordinal

2

1 reference

25 November 2017

H Y Meltzer

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

25 November 2017

1 reference

25 November 2017

907

1 reference

25 November 2017

1-2

1 reference

25 November 2017

151-155

1 reference

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Effect of the selective 5-HT receptor agonists 8-OHDPAT and DOI on behavior and brain biogenic amines of rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Molecular pharmacology and biology of 5-HT1C receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Effects of the serotonin2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

The role of serotonin in antipsychotic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

The effects of antipsychotics with 5-HT(2C) receptor affinity in behavioral assays selective for 5-HT(2C) receptor antagonist properties of compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902596-3

10.1016/S0006-8993(01)02596-3

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference